2,523
Views
13
CrossRef citations to date
0
Altmetric
Addenda

Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases

&
Article: e1251380 | Received 18 Jul 2016, Accepted 18 Oct 2016, Published online: 21 Nov 2016

References

  • Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 2016; 13(9):508-16; Jun 22 [Epub ahead of print]; PMID:27329806; http://dx.doi.org/10.1038/nrgastro.2016.98
  • Lessa FC, Winston LG, McDonald LC, Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:2369-70; PMID:26061850; http://dx.doi.org/10.1056/NEJMc1505190
  • Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002; PMID:22002980; http://dx.doi.org/10.1093/cid/cir632
  • Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107:1755; PMID:23160295; http://dx.doi.org/10.1038/ajg.2012.251
  • Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44(5):854-9; PMID:13592638
  • van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-415; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037
  • Critical views in gastroenterology & hepatology: Fecal microbiota transplantation: Where is it leading? Gastroenterol Hepatol (N Y) 2014; 10:307-9; PMID:24987314
  • Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical Microbiology and Infectious Diseases. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 2(20 Suppl):1-26; PMID:24118601; http://dx.doi.org/10.1111/1469-0691.12418
  • Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 2012; 5:403-20; PMID:23152734; http://dx.doi.org/10.1177/1756283X12453637
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821
  • Broecker F, Klumpp J, Moelling K. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection. Ann N Y Acad Sci 2016; 1372:29-41; PMID:27286042; http://dx.doi.org/10.1111/nyas.13100
  • Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015; 160:447-60; PMID:25619688; http://dx.doi.org/10.1016/j.cell.2015.01.002
  • Breitbart M, Hewson I, Felts B, Mahaffy JM, Nulton J, Salamon P, Rohwer F. Metagenomic analyses of an uncultured viral community from human feces. J Bacteriol 2003; 185:6220-3; PMID:14526037
  • Broecker F, Kube M, Klumpp J, Schuppler M, Biedermann L, Hecht J, Hombach M, Keller PM, Rogler G, Moelling K. Analysis of the intestinal microbiome of a recovered Clostridium difficile patient after fecal transplantation. Digestion 2013; 88:243-51; PMID:24335204; http://dx.doi.org/10.1159/000355955
  • Khamsi R. A gut feeling about immunity. Nat Med 2015; 21:674-6; PMID:26121192; http://dx.doi.org/10.1159/000355955
  • Antharam VC, Li E, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 2013; 51:2884-92; PMID:23804381; http://dx.doi.org/10.1128/JCM.00845-13
  • Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 2013; 16:255-61; PMID:23831042; http://dx.doi.org/10.1016/j.mib.2013.06.003
  • Moelling K. Nutrition and the microbiome. Ann N Y Acad Sci 2016; 1372:3-8; PMID:27285591; http://dx.doi.org/10.1111/nyas.13039
  • Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214; PMID:24009397; http://dx.doi.org/10.1126/science.1241214
  • Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2015; 2:ofv004; PMID:26034755; http://dx.doi.org/10.1093/ofid/ofv004
  • Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, Huerta-Cepas J, Nieuwdorp M, Salojärvi J, Voigt AY, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016; 352:586-9; PMID:27126044; http://dx.doi.org/10.1126/science.aad8852
  • Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 2013; 16:240-5; PMID:23845749; http://dx.doi.org/10.1016/j.mib.2013.06.004
  • Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, Stotland A, Wolkowicz R, Cutting AS, Doran KS, et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci U S A 2013; 110:10771-6; PMID:23690590; http://dx.doi.org/10.1073/pnas.1305923110
  • Peitzman SJ. Felix d'Herelle and bacteriophage therapy. Trans Stud Coll Physicians Phila 1969; 37:115-23; PMID:4900376
  • Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother 2001; 45:649-59; PMID:11181338
  • Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, et al. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine 2016; 4:124-37; PMID:26981577; http://dx.doi.org/10.1016/j.ebiom.2015.12.023
  • Ando H, Lemire S, Pires DP, Lu TK. Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing. Cell Syst 2015; 1:187-96; PMID:26973885
  • Doehn JM, Fischer K, Reppe K, Gutbier B, Tschernig T, Hocke AC, Fischetti VA, Löffler J, Suttorp N, Hippenstiel S, et al. Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia. J Antimicrob Chemother 2013; 68:2111-7; PMID:23633685; http://dx.doi.org/10.1093/jac/dkt131
  • Mayer MJ, Garefalaki V, Spoerl R, Narbad A, Meijers R. Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J Bacteriol 2011; 193:5477-86; PMID:21803993; http://dx.doi.org/10.1128/JB.00439-11
  • Dalmasso M, Strain R, Neve H, Franz CM, Cousin FJ, Ross RP, Hill C. Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy. PLoS One 2016; 11:e0156773; PMID:27280590; http://dx.doi.org/10.1371/journal.pone.0156773

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.